NCT02168439View on ClinicalTrials.gov

Intranasal Dexmedetomidine vs Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

June 30, 2016

Conditions
LacerationAnxiety
Interventions
DRUG

Dexmedetomidine

DRUG

Midazolam

Trial Locations (1)

15224

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

All Listed Sponsors
collaborator

University of Pittsburgh Clinical and Translational Science Institute (CTSI)

UNKNOWN

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

University of Pittsburgh

OTHER

NCT02168439 - Intranasal Dexmedetomidine vs Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair | Biotech Hunter | Biotech Hunter